nasdaq-biotech

This year's sell off in biotech stocks is starting to look a lot like last year's sell off in biotech stocks

View gallery.(Flickr/Gonzalo Iza)Biotech investors have been here before.
Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell off we saw in […]

Lim: Nasdaq 5,000 Not Different This Time

Lim: Nasdaq 5,000 Not Different This TimeMarch 3, 2015“Tech is 47% of the index … [A]t an average P/E of 21.5, the Nasdaq is still considerably more expensive than the Dow Jones industrial average, the S&P 500, European stocks, emerging market stocks, and the list goes on and on. …“[T]he Nasdaq Biotech index now trades at P/E of around 50. […]

Mixed Results

Stocks closed mixed Tuesday, lead by large cap indexes. Trading volume was light as we continue to chug-along here near highs. Biotechs were back to their winning ways as the Nasdaq Biotech index nears all time highs. Leading stocks generally outperformed, albeit by a smaller margin. CYBR extended it’s earnings related gains, yet VDSI swung wildly after announcing it’s earnings. […]